Income Statement Pacira BioSciences, Inc.

Equities

PCRX

US6951271005

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2024-09-19 pm EDT			5-day change	1st Jan Change
14.69 ^USD	+0.27%		+15.40%	-56.46%

Sep. 09	Pacira Biosciences, Inc. Announces Board Changes	CI
Aug. 13	Truist Securities Downgrades Pacira BioSciences to Sell From Buy, Adjusts Price Target to $8 From $30	MT

15cf969af4d8be67.D5j-bhun_i43hrRJOdtEoCO77194sR4-KHuWdIqsPkY.Y8isGGGWhEAaq8UFarcg6XWPpTwM1mluayujHNndRis4_YkgWN63TUfCjA

Published financial data: PACIRA BIOSCIENCES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	421M	430M	542M	667M	675M
Total Revenues	421M	430M	542M	667M	675M
Cost of Goods Sold, Total	179M	177M	196M	274M	261M
Gross Profit	242M	253M	346M	393M	414M
Selling General & Admin Expenses, Total	201M	194M	199M	255M	269M
Amortization of Goodwill and Intangible Assets - (IS)	5.7M	7.87M	13.55M	57.29M	57.29M
Other Operating Expenses, Total	206M	201M	213M	312M	327M
Operating Income	35.71M	51.52M	133M	81.43M	87.32M
Interest Expense, Total	-23.63M	-25.67M	-31.75M	-39.98M	-20.31M
Interest And Investment Income	7.38M	4.63M	896K	4.54M	11.44M
Net Interest Expenses	-16.25M	-21.04M	-30.85M	-35.43M	-8.86M
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	724K	1.23M	7K	-1.2M	-186K
EBT, Excl. Unusual Items	20.18M	31.71M	102M	44.8M	78.28M
Restructuring Charges	-159K	188K	-	-	-1.11M
Merger & Related Restructuring Charges	-4.9M	-150K	-40.9M	-11.24M	-1.96M
Gain (Loss) On Sale Of Investments	-5.7M	1.62M	-2.67M	-10.09M	-
Asset Writedown	-	-	-	-36.63M	-
Legal Settlements	-3.5M	-	-	-	-
Other Unusual Items	-16.67M	-13.28M	-2.01M	26.48M	-13.5M
EBT, Incl. Unusual Items	-10.75M	20.09M	56.4M	13.3M	61.7M
Income Tax Expense	268K	-125M	14.42M	-2.61M	19.75M
Earnings From Continuing Operations	-11.02M	146M	41.98M	15.91M	41.96M
Net Income to Company	-11.02M	146M	41.98M	15.91M	41.96M
Net Income - (IS)	-11.02M	146M	41.98M	15.91M	41.96M
Net Income to Common Incl Extra Items	-11.02M	146M	41.98M	15.91M	41.96M
Net Income to Common Excl. Extra Items	-11.02M	146M	41.98M	15.91M	41.96M
Per Share Items
Net EPS - Basic	-0.27	3.41	0.95	0.35	0.91
Basic EPS - Continuing Operations	-0.27	3.41	0.95	0.35	0.91
Basic Weighted Average Shares Outstanding	41.51M	42.67M	44.26M	45.52M	46.22M
Net EPS - Diluted	-0.27	3.33	0.92	0.34	0.89
Diluted EPS - Continuing Operations	-0.27	3.33	0.92	0.34	0.89
Diluted Weighted Average Shares Outstanding	41.51M	43.68M	45.63M	46.54M	51.98M
Normalized Basic EPS	0.3	0.46	1.44	0.62	1.06
Normalized Diluted EPS	0.3	0.45	1.4	0.6	0.94
Supplemental Items
EBITDA	49.59M	71.42M	161M	162M	163M
EBITA	35.72M	59.38M	146M	139M	145M
EBIT	35.71M	51.52M	133M	81.43M	87.32M
EBITDAR	57.47M	83.58M	175M	178M	179M
Total Revenues (As Reported)	421M	430M	542M	667M	675M
Effective Tax Rate - (Ratio)	-2.49	-624.39	25.57	-19.6	32
Current Domestic Taxes	2.1M	1.18M	3.53M	5.31M	4.13M
Current Foreign Taxes	-	-	19K	29K	1K
Total Current Taxes	2.1M	1.18M	3.55M	5.34M	4.13M
Deferred Domestic Taxes	-1.83M	-127M	10.87M	-7.94M	15.62M
Total Deferred Taxes	-1.83M	-127M	10.87M	-7.94M	15.62M
Normalized Net Income	12.61M	19.82M	63.74M	28M	48.92M
Interest Capitalized	100K	2.4M	3.9M	4.1M	3.5M
Interest on Long-Term Debt	23.65M	28.06M	35.66M	44.09M	23.83M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	77.82M	59.42M	55.54M	111M	76.26M
Net Rental Expense, Total	7.88M	12.15M	13.7M	15.68M	15.64M
Imputed Operating Lease Interest Expense	4.65M	6.11M	4.68M	5.85M	4.41M
Imputed Operating Lease Depreciation	3.22M	6.04M	9.02M	9.84M	11.22M
Stock-Based Comp., COGS (Total)	9.78M	10.8M	11.36M	12.56M	14.23M
Stock-Based Comp., SG&A Exp. (Total)	23.87M	29.12M	30.89M	35.53M	33.66M
Total Stock-Based Compensation	33.65M	39.92M	42.25M	48.09M	47.9M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	78.23M	99.96M	586M	104M	153M
Short Term Investments	214M	422M	70.83M	185M	125M
Total Cash And Short Term Investments	292M	522M	656M	289M	279M
Accounts Receivable, Total	47.53M	53.05M	96.32M	98.4M	106M
Other Receivables	-	1.6M	100K	800K	400K
Total Receivables	47.53M	54.65M	96.42M	99.2M	106M
Inventory	58.3M	64.65M	98.55M	96.06M	104M
Prepaid Expenses	10.78M	10.66M	14.67M	14.42M	20.4M
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	-	-	-	-	700K
Total Current Assets	409M	652M	866M	498M	510M
Gross Property Plant And Equipment	218M	290M	350M	372M	370M
Accumulated Depreciation	-75.44M	-78.36M	-85.24M	-117M	-135M
Net Property Plant And Equipment	143M	211M	265M	254M	235M
Long-term Investments	74.8M	107M	21.99M	64.38M	32.26M
Goodwill	99.55M	99.55M	145M	163M	163M
Other Intangibles, Total	104M	96.52M	624M	541M	483M
Deferred Tax Assets Long-Term	-	106M	153M	160M	144M
Other Long-Term Assets, Total	971K	2.42M	-	-	6.2M
Total Assets	831M	1.27B	2.08B	1.68B	1.57B
Liabilities
Accounts Payable, Total	12.8M	10.43M	10.54M	15.22M	15.7M
Accrued Expenses, Total	68.4M	68.78M	119M	82.49M	55.72M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	150M	375M	33.65M	8.64M
Current Portion of Leases	4.94M	7.42M	7.89M	9.12M	8.8M
Current Income Taxes Payable	1.33M	114K	429K	-	-
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	20.2M	16.93M	8.95M	7.3M	8.53M
Total Current Liabilities	108M	253M	521M	148M	97.38M
Long-Term Debt	306M	313M	675M	656M	514M
Long-Term Leases	40.94M	71.02M	71.73M	64.8M	54.81M
Unearned Revenue Non Current	-	-	10.12M	-	-
Other Non Current Liabilities	21.46M	17.44M	67.44M	37.79M	38.27M
Total Liabilities	476M	655M	1.34B	906M	704M
Common Stock, Total	42K	44K	45K	46K	46K
Additional Paid In Capital	754M	873M	942M	924M	977M
Retained Earnings	-399M	-254M	-212M	-149M	-107M
Comprehensive Income and Other	322K	318K	167K	-380K	247K
Total Common Equity	355M	620M	730M	775M	870M
Total Equity	355M	620M	730M	775M	870M
Total Liabilities And Equity	831M	1.27B	2.08B	1.68B	1.57B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	42.03M	43.86M	44.85M	45.95M	46.5M
ECS Total Common Shares Outstanding	41.91M	43.64M	44.73M	45.93M	46.48M
Book Value / Share	8.47	14.2	16.33	16.87	18.72
Tangible Book Value	151M	424M	-38.74M	71.22M	224M
Tangible Book Value Per Share	3.6	9.71	-0.87	1.55	4.81
Total Debt	352M	541M	1.13B	763M	586M
Net Debt	59.97M	19.47M	472M	475M	307M
Debt Equivalent Oper. Leases	63.01M	97.21M	110M	125M	125M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	20.02M	26.89M	36.34M	39.81M	54.1M
Inventories - Work In Process, Total	14.41M	16.27M	35.18M	28.85M	31.22M
Inventories - Finished Goods, Total	23.87M	21.5M	27.03M	27.4M	19.04M
Machinery, Total	80.9M	89.52M	133M	136M	142M
Full Time Employees	606	624	697	715	711
Part Time Employees	-	-	-	-	1

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-11.02M	146M	41.98M	15.91M	41.96M
Depreciation & Amortization - CF	13.87M	12.04M	15M	23.71M	18.29M
Amortization of Goodwill and Intangible Assets - (CF)	7K	7.87M	13.55M	57.29M	57.29M
Depreciation & Amortization, Total	13.88M	19.91M	28.55M	81M	75.57M
Amortization of Deferred Charges, Total - (CF)	21.15M	20.41M	25.91M	7.21M	3.75M
(Gain) Loss From Sale Of Asset	1.01M	22K	-10K	193K	-
(Gain) Loss on Sale of Investments - (CF)	4.32M	-1.62M	2.67M	10.09M	-
Asset Writedown & Restructuring Costs	-	-	-	36.63M	-
Stock-Based Compensation (CF)	33.65M	39.92M	42.25M	48.09M	47.9M
Other Operating Activities, Total	16.67M	-113M	9.88M	-37.42M	31.25M
Change In Accounts Receivable	-8.52M	-5.52M	-10.43M	-2.08M	-7.16M
Change In Inventories	-8.03M	-6.35M	-4.47M	2.49M	-8.29M
Change In Accounts Payable	-1.82M	-3.31M	-10.26M	6.27M	916K
Change in Unearned Revenues	-	-	125K	-	-
Change in Other Net Operating Assets	9.23M	-18.61M	-471K	-23.11M	-31.24M
Cash from Operations	70.52M	77.03M	126M	145M	155M
Capital Expenditure	-10.16M	-37.8M	-45.87M	-30.08M	-15.16M
Cash Acquisitions	-118M	-	-424M	-32M	-
Investment in Marketable and Equity Securities, Total	-638K	-240M	449M	-163M	92.7M
Cash from Investing	-128M	-278M	-20.79M	-225M	77.54M
Long-Term Debt Issued, Total	-	315M	364M	-	150M
Total Debt Issued	-	315M	364M	-	150M
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-338K	-177M	-	-428M	-330M
Total Debt Repaid	-338K	-177M	-	-428M	-330M
Issuance of Common Stock	10.87M	136M	26.66M	27.34M	4.75M
Repurchase of Common Stock	-	-33.09M	-	-	-106K
Other Financing Activities, Total	-6.86M	-18.08M	-9.71M	-1.18M	-6.91M
Cash from Financing	3.67M	222M	381M	-402M	-183M
Net Change in Cash	-54.3M	21.73M	486M	-481M	49.16M
Supplemental Items
Cash Interest Paid	8.2M	7.2M	7M	33.3M	27.64M
Cash Income Tax Paid (Refund)	863K	2.42M	3.22M	7.4M	4.37M
Levered Free Cash Flow	86.39M	38.75M	76.61M	98.56M	107M
Unlevered Free Cash Flow	85.71M	34.39M	70.54M	116M	116M
Change In Net Working Capital	-20.32M	19.84M	37.41M	33.57M	46.79M
Net Debt Issued / Repaid	-338K	138M	364M	-428M	-181M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	2.94	3.06	4.96	2.71	3.35
Return on Total Capital	3.38	3.45	5.5	3	3.64
Return On Equity %	-3.26	29.86	6.22	2.11	5.1
Return on Common Equity	-3.26	29.86	6.22	2.11	5.1
Margin Analysis
Gross Profit Margin %	57.52	58.86	63.84	58.97	61.34
SG&A Margin	47.69	45.04	36.81	38.17	39.92
EBITDA Margin %	11.78	16.62	29.8	24.36	24.13
EBITA Margin %	8.48	13.82	27.03	20.8	21.42
EBIT Margin %	8.48	11.99	24.53	12.21	12.94
Income From Continuing Operations Margin %	-2.62	33.87	7.75	2.39	6.22
Net Income Margin %	-2.62	33.87	7.75	2.39	6.22
Net Avail. For Common Margin %	-2.62	33.87	7.75	2.39	6.22
Normalized Net Income Margin	3	4.61	11.77	4.2	7.25
Levered Free Cash Flow Margin	20.52	9.02	14.15	14.78	15.87
Unlevered Free Cash Flow Margin	20.36	8	13.03	17.45	17.2
Asset Turnover
Asset Turnover	0.55	0.41	0.32	0.36	0.41
Fixed Assets Turnover	3.35	2.43	2.28	2.57	2.76
Receivables Turnover (Average Receivables)	9.85	8.54	7.25	6.85	6.62
Inventory Turnover (Average Inventory)	3.35	2.88	2.4	2.81	2.6
Short Term Liquidity
Current Ratio	3.79	2.57	1.66	3.37	5.24
Quick Ratio	3.15	2.27	1.44	2.62	3.95
Operating Cash Flow to Current Liabilities	0.65	0.3	0.24	0.98	1.59
Days Sales Outstanding (Average Receivables)	37.07	42.84	50.34	53.29	55.14
Days Outstanding Inventory (Average Inventory)	109.06	127.29	152.11	129.82	140.18
Average Days Payable Outstanding	26.29	23.22	16.66	17.34	20.96
Cash Conversion Cycle (Average Days)	119.84	146.92	185.79	165.76	174.36
Long Term Solvency
Total Debt/Equity	99.15	87.32	154.55	98.5	67.35
Total Debt / Total Capital	49.79	46.62	60.72	49.62	40.25
LT Debt/Equity	97.76	61.98	102.17	92.98	65.35
Long-Term Debt / Total Capital	49.09	33.08	40.14	46.84	39.05
Total Liabilities / Total Assets	57.29	51.38	64.81	53.9	44.73
EBIT / Interest Expense	1.51	2.01	4.18	2.04	4.3
EBITDA / Interest Expense